Opinion: Medicare Part B needs reform, but Trump’s proposal faces insurmountable challenges

Medicare Part B needs reform, but I worry that Trump's plan will meet the same ruinous fate as prior proposals.
President Trump announces a plan to overhaul how Medicare pays for certain drugs during a speech Thursday at the Department of Health and Human Services in Washington. Source: Chip Somodevilla/Getty Images

President Trump’s timely speech Thursday about high drug prices addressed key problems that make drugs unaffordable for so many Americans, and for taxpayers in general. With less than two weeks until the midterm elections, and drug prices a key issue for voters, the speech sent a message that the administration recognizes voters’ concerns, and is doing something about them.

Although the effort put into addressing drug pricing by the Trump administration is impressive, the solutions proposed Thursday face insurmountable challenges. I worry that the plan will meet the same (ruinous) fate as prior proposals

Sie lesen eine Vorschau. Registrieren Sie sich, um mehr zu lesen.

Mehr von STAT

STAT1 min gelesenSociety
STAT Plus: Pharmalittle: Coronavirus Vaccine May Not Be A Cure-all; Hydroxychloroquine Fails In A Covid-19 Study
#Covid19 vaccines in development may be more like those that protect against influenza — reducing the risk of contracting the disease and of experiencing severe symptoms should infection occur.
STAT1 min gelesenSociety
STAT Plus: Pharmalittle: Hydroxychloroquine Fails To Help Patients In A Study; What Will States Do With The Old Malaria Drug Now?
After doubts arose about whether hydroxychloroquine is safe and effective for treating Covid-19, states are donating supplies to patients who need them to treat other illnesses or seeking refunds.
STAT1 min gelesen
STAT Plus: Pharmalittle: Sanofi Walks Back Covid-19 Vaccine Remarks; Trump To Name Vaccine Czar With Conflicts
Sanofi insisted it would make its Covid-19 vaccine available in all countries, hours after chief executive Paul Hudson said the U.S. will get first access.